Nutritional supplements that contain curcumin -- a natural anti-inflammatory compound -- may protect the eyes from the ...

The therapy, called photobiomodulation or “red light” therapy, can reduce the risk of vision loss and slow progression of the ...

Preliminary data from a late stage clinical trial of a retinal implant showed promising results, Science Corporation said ...

CHICAGO -- Availability of a bevacizumab biosimilar for ophthalmic use could eliminate a lower-cost treatment option for a ...

Patients with neovascular age-related macular degeneration diagnosed by a primary care clinician may be more likely to miss ...

In data presented at the 128th annual meeting of the American Academy of Ophthalmology in Chicago, the two-year study finds ...

Analyst Yi Chen of H.C. Wainwright reiterated a Buy rating on EyePoint Pharmaceuticals (EYPT – Research Report), retaining the price ...

Pharmaceuticals announced that the first patient has been dosed in the Phase 3 LUGANO clinical trial of DURAVYU, formerly ...

According to Research by SNS Insider, Dry AMD Market Growth is Driven by New Therapies, Geriatric Population Boom, and Advancements in R&D.Pune, Oct. 17, 2024 (GLOBE NEWSWIRE) -- SNS Insider reports ...

The following is a summary of “Submacular hemorrhage rates following anti-vascular endothelial growth factor injections for ...

A recent study, published in the journal Nature looked into the six-month impact of switching to faricimab instead of ...